EMD Pharmaceuticals To Build German Biomanufacturing Plant

Published March 2003

JENA, GERMANY -

EMD Pharmaceuticals, the U.S. subsidiary of Darmstadt, Germany-based Merck KGaA, will construct a $300-million biomanufacturing plant in Jena, Germany. The 200,000-sf facility will manufacture cancer drugs.

Copyright 2008 Tradeline Inc.
All Rights Reserved
ISSN: 1096-4894